The Abscopal Effect in the Era of Cancer Immunotherapy: a Spontaneous Synergism Boosting Anti-tumor Immunity? Zuzana HlavataCinzia SolinasMario Scartozzi Leading Article 22 February 2018 Pages: 113 - 123
Modulating Tumor Immunology by Inhibiting Indoleamine 2,3-Dioxygenase (IDO): Recent Developments and First Clinical Experiences Diwakar DavarNathan Bahary Review Article 04 January 2018 Pages: 125 - 140
Treatment of EGFR T790M-Positive Non-Small Cell Lung Cancer Joan Rou-En ChooChee-Seng TanRoss A. Soo Review Article 08 February 2018 Pages: 141 - 156
Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies Josh W. DiGiacomoDaniele M. Gilkes Review Article 08 February 2018 Pages: 157 - 173
Extracellular Vesicles As miRNA Nano-Shuttles: Dual Role in Tumor Progression Marzia PucciPablo Reclusa AsiáinSimona Taverna Review Article 26 January 2018 Pages: 175 - 187
Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations Mehran MakvandiEdouard DupisJeffrey P. Norenberg Review Article 08 February 2018 Pages: 189 - 203
Cabozantinib Versus Standard-of-Care Comparators in the Treatment of Advanced/Metastatic Renal Cell Carcinoma in Treatment-naïve Patients: a Systematic Review and Network Meta-Analysis Elvira SchmidtJohanna ListerFlorence Marteau Original Research Article Open access 28 February 2018 Pages: 205 - 216
Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience Ofer PurimAlexander BenyAyala Hubert Original Research Article Open access 20 January 2018 Pages: 217 - 226
Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study Maria Di BartolomeoMonica NigerFerdinando De Vita Original Research Article 27 March 2018 Pages: 227 - 234
Combining Ibrutinib with Chk1 Inhibitors Synergistically Targets Mantle Cell Lymphoma Cell Lines Valentina RestelliMonica LupiLaura Carrassa Original Research Article 13 February 2018 Pages: 235 - 245
Induction chemotherapy with the EXTREME regimen in frail patients with locally advanced head and neck squamous cell carcinoma Valérie CochinErwan de MonesAmaury Daste Short Communication 05 February 2018 Pages: 247 - 252
Retreatment with Vismodegib after Progression in Advanced Basal Cell Carcinoma: First-Time Report of a Single-Institution Experience Salvatore AlfieriCristiana BergaminiPaolo Bossi Therapy in Practice 12 December 2017 Pages: 253 - 256